https://www.cochrane.org/hr/evidence/CD009145_bezafibrate-primary-biliary-cirrhosis
Bezafibrate for primary biliary cirrhosis | Cochrane
primary biliary cirrhosisbezafibratecochrane
https://pmc.ncbi.nlm.nih.gov/articles/PMC7059007/
Metabolic effects of bezafibrate in mitochondrial disease - PMC
Mitochondrial disorders affect 1/5,000 and have no cure. Inducing mitochondrial biogenesis with bezafibrate improves mitochondrial function in animal models,...
mitochondrial diseasemetaboliceffectsbezafibratepmc
https://www.researchandmarkets.com/report/bezafibrate
Bezafibrate (CAS 41859-67-0) Industry Research 2025
Bezafibrate (CAS 41859-67-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029
industry researchbezafibratecas670